BioReason Chat Export

Exported on March 22, 2026 at 02:28 AM

Organism: Pseudomonas putida

Sequence:

MIRLLKFFWWSSVAVICALVLGVSGAFLYLSPSLPSVESLRSIQLQIPLRVYSSDGKLIAEFGEMRRSPIRFAEIPPQFIQALLSAEDDNFLNHYGVDPSSLMRAATQLVKTGHIQTGGSTITMQVAKNFFLTSERSFSRKTNEILLALQIERELTKDEILELYVNKIYLGNRAYGIDAAAQVYYGKSIRDVSLAQMAMIAGLPKAPSRFNPLANPVRAKERRDWILGRMYKLGKIDQASYEAALAEPLNASYHVPTPEVNAPYIAEMARAEMVGRYGSDAYTEGFRVTTTVPSDMQEMANKAVLKGLSDYDERHGYRGPEARFPGRTQAAWLQELGKQRTLGGLEPAIVTQVEHTGLKVLTRDGQEAQVAWDTMKWARPFINNNAQGRSPQSPADVAQVGDLVRLQRLDDGTLKFSQVPVAQSALVTLDPNNGAIRALVGGFSFEQSNYNRAVQAKRQPGSSFKPFIYSAALDSGYTASSLVNDAPIVFVDESVDKVWRPKNDTNTFLGPIRMREALYKSRNLVSIRLLQAMGVDRTIDYIAKFGFNKQDLPRNLSLALGTATLTPMEIATGWSTFANGGYKITPYLIERIESRSGETLFTANPARVPQGAQDQAGLAAPEQPISTAAMPGEAPSAFSQVAAASQAPAVAEQIIDGRTTYILTSMLQDVIKRGTGRRALALGRTDLAGKTGTTNESKDAWFSGYNADYVTTVWVGFDQPETLGRREYGGTAALPIWMNFMGAALKDKPAHAPAEPEGILSLRVDPVSGRAASPSTPNAYFELFKAEDSPPSVDELGNGAAPGSPLPADEATPMDLF

Thinking Trace

The architecture begins with IPR050396 (Glycosyltransferase 51/Transpeptidase family, residues 5–794), which blankets nearly the full length and establishes a bifunctional scaffold typical of Gram‑negative peptidoglycan assembly enzymes. The N‑terminal third is densely annotated by IPR023346 (Lysozyme-like domain superfamily, residues 44–256), IPR036950 (Transglycosylase domain superfamily, residues 49–244), and IPR001264 (Glycosyl transferase, family 51, residues 55–230). This trio defines a soluble N‑terminal transglycosylase module that polymerizes lipid‑anchored glycan strands; lysozyme-like and GT51 signatures together specify catalytic chemistry that forms β‑1,4 linkages in peptidoglycan precursors. The C‑terminal two‑thirds are defined by IPR012338 (Beta-lactamase/transpeptidase-like superfamily, residues 212–795) and the embedded IPR001460 (Penicillin-binding protein, transpeptidase domain, residues 426–741), with an accessory IPR031376 (Penicillin-binding protein, OB-like domain, residues 317–421) bridging the two halves. This C‑terminal module forms and cross-links peptide stems and is intrinsically susceptible to covalent acylation by β‑lactam antibiotics, a hallmark of class A penicillin-binding proteins. The ordered layout—an N‑terminal GT51 transglycosylase followed by a C‑terminal PBPs/transpeptidase—causes a bifunctional assembly machine that both elongates and cross-links the sacculus.

From this architecture, the molecular functions resolve into two axes. First, the N‑terminal GT51/transglycosylase block directly drives glycan polymerization chemistry; second, the C‑terminal transpeptidase/PBPs block executes peptide cross-linking and binds β‑lactam antibiotics. The explicit PBPs/transpeptidase core supports penicillin-binding capability and β‑lactamase-like chemistry, while the OB-like insert stabilizes ligand and substrate capture. Together, these features justify penicillin binding as a defining molecular function and situate the enzyme within the peptidoglycan assembly pathway.

These catalytic activities necessarily feed the biological process of peptidoglycan biosynthesis and cell wall biogenesis. The transglycosylase builds linear tetrapeptide repeats that are subsequently cross-linked, and the transpeptidase domain enacts the cross-linking step that stiffens the sacculus. This causal chain anchors the enzyme within the broader program of peptidoglycan biosynthetic process and cell wall organization.

Cellular placement follows from the absence of transmembrane segments in the annotated regions and the soluble GT51/transpeptidase fold: the enzyme operates on the cytoplasmic side of the inner membrane where lipid II precursors are generated and handled. Thus, a cytoplasmic localization is expected for its functional cycle, consistent with soluble assembly factors that transiently associate with membrane-derived intermediates.

Mechanistically, the protein likely coordinates with upstream and downstream envelope biogenesis modules. The N‑terminal transglycosylase would hand off elongated glycan strands to the C‑terminal cross-linking core, with the OB-like insert choreographing substrate channeling. Hypothesized interaction partners include membrane-associated glycan precursor pathways and periplasmic transpeptidases that finalize cross-links after export; soluble scaffolds and chaperones in the cytoplasm could transiently stabilize the bifunctional assembly line. Inhibition by β‑lactams would be expected due to the C‑terminal transpeptidase/PBP chemistry, further reinforcing its antibiotic-susceptible role in cell wall construction.

Functional Summary

A soluble, bifunctional enzyme in Pseudomonas putida that assembles the bacterial cell wall. Its N-terminal module polymerizes glycan strands from lipid-linked precursors, while its C-terminal module cross-links peptide stems and is intrinsically susceptible to β-lactam antibiotics. Acting on the cytoplasmic side of the envelope, it couples glycan elongation with peptide cross-linking to drive peptidoglycan biosynthesis and cell wall maturation.

UniProt Summary

Cell wall formation.

InterPro Domains

• Glycosyltransferase 51/Transpeptidase (IPR050396, family) — residues 5-794
• Lysozyme-like domain superfamily (IPR023346, homologous_superfamily) — residues 44-256
• Transglycosylase domain (IPR036950, homologous_superfamily) — residues 49-244
• Glycosyl transferase, family 51 (IPR001264, domain) — residues 55-230
• Beta-lactamase/transpeptidase-like (IPR012338, homologous_superfamily) — residues 212-795
• Penicillin-binding protein, OB-like domain (IPR031376, domain) — residues 317-421
• Penicillin-binding protein, transpeptidase (IPR001460, domain) — residues 426-741

GO Terms

Molecular Function: molecular_function (GO:0003674), binding (GO:0005488), sulfur compound binding (GO:1901681), small molecule binding (GO:0036094), organic cyclic compound binding (GO:0097159), amide binding (GO:0033218), heterocyclic compound binding (GO:1901363), ion binding (GO:0043167), anion binding (GO:0043168), organic acid binding (GO:0043177), carboxylic acid binding (GO:0031406), monocarboxylic acid binding (GO:0033293)

Biological Process: biological_process (GO:0008150), metabolic process (GO:0008152), cellular process (GO:0009987), biosynthetic process (GO:0009058), cellular metabolic process (GO:0044237), cell wall organization or biogenesis (GO:0071554), nitrogen compound metabolic process (GO:0006807), cellular component organization or biogenesis (GO:0071840), organic substance metabolic process (GO:0071704), cell wall macromolecule metabolic process (GO:0044036), cellular component biogenesis (GO:0044085), organonitrogen compound metabolic process (GO:1901564), organic substance biosynthetic process (GO:1901576), cell wall biogenesis (GO:0042546), cellular biosynthetic process (GO:0044249), cellular macromolecule metabolic process (GO:0044260), macromolecule metabolic process (GO:0043170), carbohydrate derivative metabolic process (GO:1901135), organonitrogen compound biosynthetic process (GO:1901566), macromolecule biosynthetic process (GO:0009059), cellular component macromolecule biosynthetic process (GO:0070589), peptidoglycan-based cell wall biogenesis (GO:0009273), cellular macromolecule biosynthetic process (GO:0034645), carbohydrate derivative biosynthetic process (GO:1901137), cell wall macromolecule biosynthetic process (GO:0044038), aminoglycan metabolic process (GO:0006022), glycosaminoglycan metabolic process (GO:0030203), aminoglycan biosynthetic process (GO:0006023), peptidoglycan biosynthetic process (GO:0009252), glycosaminoglycan biosynthetic process (GO:0006024), peptidoglycan metabolic process (GO:0000270)

Cellular Component: cellular_component (GO:0005575), cellular anatomical entity (GO:0110165), envelope (GO:0031975), cell periphery (GO:0071944), periplasmic space (GO:0042597), membrane (GO:0016020), plasma membrane (GO:0005886), cell envelope (GO:0030313), outer membrane-bounded periplasmic space (GO:0030288)

Generated by BioReason

BioReason Chat Export

Exported on March 22, 2026 at 02:28 AM

Organism: Pseudomonas putida

Sequence:

MIRLLKFFWWSSVAVICALVLGVSGAFLYLSPSLPSVESLRSIQLQIPLRVYSSDGKLIAEFGEMRRSPIRFAEIPPQFIQALLSAEDDNFLNHYGVDPSSLMRAATQLVKTGHIQTGGSTITMQVAKNFFLTSERSFSRKTNEILLALQIERELTKDEILELYVNKIYLGNRAYGIDAAAQVYYGKSIRDVSLAQMAMIAGLPKAPSRFNPLANPVRAKERRDWILGRMYKLGKIDQASYEAALAEPLNASYHVPTPEVNAPYIAEMARAEMVGRYGSDAYTEGFRVTTTVPSDMQEMANKAVLKGLSDYDERHGYRGPEARFPGRTQAAWLQELGKQRTLGGLEPAIVTQVEHTGLKVLTRDGQEAQVAWDTMKWARPFINNNAQGRSPQSPADVAQVGDLVRLQRLDDGTLKFSQVPVAQSALVTLDPNNGAIRALVGGFSFEQSNYNRAVQAKRQPGSSFKPFIYSAALDSGYTASSLVNDAPIVFVDESVDKVWRPKNDTNTFLGPIRMREALYKSRNLVSIRLLQAMGVDRTIDYIAKFGFNKQDLPRNLSLALGTATLTPMEIATGWSTFANGGYKITPYLIERIESRSGETLFTANPARVPQGAQDQAGLAAPEQPISTAAMPGEAPSAFSQVAAASQAPAVAEQIIDGRTTYILTSMLQDVIKRGTGRRALALGRTDLAGKTGTTNESKDAWFSGYNADYVTTVWVGFDQPETLGRREYGGTAALPIWMNFMGAALKDKPAHAPAEPEGILSLRVDPVSGRAASPSTPNAYFELFKAEDSPPSVDELGNGAAPGSPLPADEATPMDLF

Thinking Trace

The architecture begins with IPR050396 (Glycosyltransferase 51/Transpeptidase family, residues 5–794), which blankets nearly the full length and establishes a bifunctional scaffold typical of Gram‑negative peptidoglycan assembly enzymes. The N‑terminal third is densely annotated by IPR023346 (Lysozyme-like domain superfamily, residues 44–256), IPR036950 (Transglycosylase domain superfamily, residues 49–244), and IPR001264 (Glycosyl transferase, family 51, residues 55–230). This trio defines a soluble N‑terminal transglycosylase module that polymerizes lipid‑anchored glycan strands; lysozyme-like and GT51 signatures together specify catalytic chemistry that forms β‑1,4 linkages in peptidoglycan precursors. The C‑terminal two‑thirds are defined by IPR012338 (Beta-lactamase/transpeptidase-like superfamily, residues 212–795) and the embedded IPR001460 (Penicillin-binding protein, transpeptidase domain, residues 426–741), with an accessory IPR031376 (Penicillin-binding protein, OB-like domain, residues 317–421) bridging the two halves. This C‑terminal module forms and cross-links peptide stems and is intrinsically susceptible to covalent acylation by β‑lactam antibiotics, a hallmark of class A penicillin-binding proteins. The ordered layout—an N‑terminal GT51 transglycosylase followed by a C‑terminal PBPs/transpeptidase—causes a bifunctional assembly machine that both elongates and cross-links the sacculus.

From this architecture, the molecular functions resolve into two axes. First, the N‑terminal GT51/transglycosylase block directly drives glycan polymerization chemistry; second, the C‑terminal transpeptidase/PBPs block executes peptide cross-linking and binds β‑lactam antibiotics. The explicit PBPs/transpeptidase core supports penicillin-binding capability and β‑lactamase-like chemistry, while the OB-like insert stabilizes ligand and substrate capture. Together, these features justify penicillin binding as a defining molecular function and situate the enzyme within the peptidoglycan assembly pathway.

These catalytic activities necessarily feed the biological process of peptidoglycan biosynthesis and cell wall biogenesis. The transglycosylase builds linear tetrapeptide repeats that are subsequently cross-linked, and the transpeptidase domain enacts the cross-linking step that stiffens the sacculus. This causal chain anchors the enzyme within the broader program of peptidoglycan biosynthetic process and cell wall organization.

Cellular placement follows from the absence of transmembrane segments in the annotated regions and the soluble GT51/transpeptidase fold: the enzyme operates on the cytoplasmic side of the inner membrane where lipid II precursors are generated and handled. Thus, a cytoplasmic localization is expected for its functional cycle, consistent with soluble assembly factors that transiently associate with membrane-derived intermediates.

Mechanistically, the protein likely coordinates with upstream and downstream envelope biogenesis modules. The N‑terminal transglycosylase would hand off elongated glycan strands to the C‑terminal cross-linking core, with the OB-like insert choreographing substrate channeling. Hypothesized interaction partners include membrane-associated glycan precursor pathways and periplasmic transpeptidases that finalize cross-links after export; soluble scaffolds and chaperones in the cytoplasm could transiently stabilize the bifunctional assembly line. Inhibition by β‑lactams would be expected due to the C‑terminal transpeptidase/PBP chemistry, further reinforcing its antibiotic-susceptible role in cell wall construction.

Functional Summary

A soluble, bifunctional enzyme in Pseudomonas putida that assembles the bacterial cell wall. Its N-terminal module polymerizes glycan strands from lipid-linked precursors, while its C-terminal module cross-links peptide stems and is intrinsically susceptible to β-lactam antibiotics. Acting on the cytoplasmic side of the envelope, it couples glycan elongation with peptide cross-linking to drive peptidoglycan biosynthesis and cell wall maturation.

UniProt Summary

Cell wall formation.

InterPro Domains

• Glycosyltransferase 51/Transpeptidase (IPR050396, family) — residues 5-794
• Lysozyme-like domain superfamily (IPR023346, homologous_superfamily) — residues 44-256
• Transglycosylase domain (IPR036950, homologous_superfamily) — residues 49-244
• Glycosyl transferase, family 51 (IPR001264, domain) — residues 55-230
• Beta-lactamase/transpeptidase-like (IPR012338, homologous_superfamily) — residues 212-795
• Penicillin-binding protein, OB-like domain (IPR031376, domain) — residues 317-421
• Penicillin-binding protein, transpeptidase (IPR001460, domain) — residues 426-741

GO Terms

Molecular Function: molecular_function (GO:0003674), binding (GO:0005488), sulfur compound binding (GO:1901681), small molecule binding (GO:0036094), organic cyclic compound binding (GO:0097159), amide binding (GO:0033218), heterocyclic compound binding (GO:1901363), ion binding (GO:0043167), anion binding (GO:0043168), organic acid binding (GO:0043177), carboxylic acid binding (GO:0031406), monocarboxylic acid binding (GO:0033293)

Biological Process: biological_process (GO:0008150), metabolic process (GO:0008152), cellular process (GO:0009987), biosynthetic process (GO:0009058), cellular metabolic process (GO:0044237), cell wall organization or biogenesis (GO:0071554), nitrogen compound metabolic process (GO:0006807), cellular component organization or biogenesis (GO:0071840), organic substance metabolic process (GO:0071704), cell wall macromolecule metabolic process (GO:0044036), cellular component biogenesis (GO:0044085), organonitrogen compound metabolic process (GO:1901564), organic substance biosynthetic process (GO:1901576), cell wall biogenesis (GO:0042546), cellular biosynthetic process (GO:0044249), cellular macromolecule metabolic process (GO:0044260), macromolecule metabolic process (GO:0043170), carbohydrate derivative metabolic process (GO:1901135), organonitrogen compound biosynthetic process (GO:1901566), macromolecule biosynthetic process (GO:0009059), cellular component macromolecule biosynthetic process (GO:0070589), peptidoglycan-based cell wall biogenesis (GO:0009273), cellular macromolecule biosynthetic process (GO:0034645), carbohydrate derivative biosynthetic process (GO:1901137), cell wall macromolecule biosynthetic process (GO:0044038), aminoglycan metabolic process (GO:0006022), glycosaminoglycan metabolic process (GO:0030203), aminoglycan biosynthetic process (GO:0006023), peptidoglycan biosynthetic process (GO:0009252), glycosaminoglycan biosynthetic process (GO:0006024), peptidoglycan metabolic process (GO:0000270)

Cellular Component: cellular_component (GO:0005575), cellular anatomical entity (GO:0110165), envelope (GO:0031975), cell periphery (GO:0071944), periplasmic space (GO:0042597), membrane (GO:0016020), plasma membrane (GO:0005886), cell envelope (GO:0030313), outer membrane-bounded periplasmic space (GO:0030288)

Generated by BioReason

provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2026-01-30T23:25:00.962336'
end_time: '2026-01-30T23:31:01.349621'
duration_seconds: 360.39
template_file: templates/gene_research_go_focused.md
template_variables:
organism: PSEPK
gene_id: mrcA
gene_symbol: mrcA
uniprot_accession: Q88CU6
protein_description: 'RecName: Full=Penicillin-binding protein 1A {ECO:0000256|ARBA:ARBA00018638};
EC=2.4.99.28 {ECO:0000256|ARBA:ARBA00044770}; EC=3.4.16.4 {ECO:0000256|ARBA:ARBA00012448};'
gene_info: Name=mrcA {ECO:0000313|EMBL:AAN70649.1}; OrderedLocusNames=PP_5084 {ECO:0000313|EMBL:AAN70649.1};
organism_full: Pseudomonas putida (strain ATCC 47054 / DSM 6125 / CFBP 8728 / NCIMB
11950 / KT2440).
protein_family: In the N-terminal section; belongs to the
protein_domains: Beta-lactam/transpept-like. (IPR012338); Glyco_trans_51. (IPR001264);
Glycosyltr_51/Transpeptidase. (IPR050396); Lysozyme-like_dom_sf. (IPR023346);
PBP_transglycosylase. (IPR036950)
provider_config:
timeout: 600
max_retries: 3
parameters:
allowed_domains: []
temperature: 0.1
citation_count: 17

Question

Gene Research for Functional Annotation

⚠️ CRITICAL: Gene/Protein Identification Context

BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

Target Gene/Protein Identity (from UniProt):

• UniProt Accession: Q88CU6
• Protein Description: RecName: Full=Penicillin-binding protein 1A {ECO:0000256|ARBA:ARBA00018638}; EC=2.4.99.28 {ECO:0000256|ARBA:ARBA00044770}; EC=3.4.16.4 {ECO:0000256|ARBA:ARBA00012448};
• Gene Information: Name=mrcA {ECO:0000313|EMBL:AAN70649.1}; OrderedLocusNames=PP_5084 {ECO:0000313|EMBL:AAN70649.1};
• Organism (full): Pseudomonas putida (strain ATCC 47054 / DSM 6125 / CFBP 8728 / NCIMB 11950 / KT2440).
• Protein Family: In the N-terminal section; belongs to the
• Key Domains: Beta-lactam/transpept-like. (IPR012338); Glyco_trans_51. (IPR001264); Glycosyltr_51/Transpeptidase. (IPR050396); Lysozyme-like_dom_sf. (IPR023346); PBP_transglycosylase. (IPR036950)

MANDATORY VERIFICATION STEPS:

1. Check if the gene symbol "mrcA" matches the protein description above
2. Verify the organism is correct: Pseudomonas putida (strain ATCC 47054 / DSM 6125 / CFBP 8728 / NCIMB 11950 / KT2440).
3. Check if protein family/domains align with what you find in literature
4. If you find literature for a DIFFERENT gene with the same or similar symbol, STOP

If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'mrcA' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

Research Target:

Please provide a comprehensive research report on the gene mrcA (gene ID: mrcA, UniProt: Q88CU6) in PSEPK.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

Gene Research for Functional Annotation

⚠️ CRITICAL: Gene/Protein Identification Context

BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

Target Gene/Protein Identity (from UniProt):

• UniProt Accession: Q88CU6
• Protein Description: RecName: Full=Penicillin-binding protein 1A {ECO:0000256|ARBA:ARBA00018638}; EC=2.4.99.28 {ECO:0000256|ARBA:ARBA00044770}; EC=3.4.16.4 {ECO:0000256|ARBA:ARBA00012448};
• Gene Information: Name=mrcA {ECO:0000313|EMBL:AAN70649.1}; OrderedLocusNames=PP_5084 {ECO:0000313|EMBL:AAN70649.1};
• Organism (full): Pseudomonas putida (strain ATCC 47054 / DSM 6125 / CFBP 8728 / NCIMB 11950 / KT2440).
• Protein Family: In the N-terminal section; belongs to the
• Key Domains: Beta-lactam/transpept-like. (IPR012338); Glyco_trans_51. (IPR001264); Glycosyltr_51/Transpeptidase. (IPR050396); Lysozyme-like_dom_sf. (IPR023346); PBP_transglycosylase. (IPR036950)

MANDATORY VERIFICATION STEPS:

1. Check if the gene symbol "mrcA" matches the protein description above
2. Verify the organism is correct: Pseudomonas putida (strain ATCC 47054 / DSM 6125 / CFBP 8728 / NCIMB 11950 / KT2440).
3. Check if protein family/domains align with what you find in literature
4. If you find literature for a DIFFERENT gene with the same or similar symbol, STOP

If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'mrcA' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

Research Target:

Please provide a comprehensive research report on the gene mrcA (gene ID: mrcA, UniProt: Q88CU6) in PSEPK.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Plan and approach
We first verified target identity and domain architecture, then gathered recent (2023–2024) and authoritative literature on class A penicillin-binding proteins (aPBPs), prioritizing Pseudomonas-focused sources where available. We synthesized enzymology, regulation, cellular localization, pathway context, and organism-specific insights (Pseudomonas and E. coli as reference Gram-negative models). Finally, we organized current applications and expert perspectives, and summarize key facts in an artifact table. (URLs are provided inline; formal support is cited using context IDs.)

Table: Concise, evidence-linked summary of Pseudomonas putida KT2440 mrcA (PBP1A, UniProt Q88CU6) covering identity, domains, activities, substrates, inhibitors, localization, regulation, roles, essentiality, and recent (2023–2024) findings; citations indicate the supporting context IDs.

1) Key concepts and definitions with current understanding
- Identity and domain architecture: mrcA encodes Penicillin-binding protein 1A (PBP1A), a class A high-molecular-mass PBP. aPBPs are bifunctional cell-wall synthases with an N-terminal membrane anchor and large periplasmic catalytic modules: a glycosyltransferase (GT) domain and a D,D-transpeptidase (TP) domain; noncatalytic regions serve as docking platforms for regulators. This architecture and role are conserved across Gram-negative bacteria, including Pseudomonas species (reviewed in Pazos & Vollmer 2021; Typas et al. 2010). https://doi.org/10.1016/j.mib.2021.01.008; https://doi.org/10.1016/j.cell.2010.11.038 (pazos2021regulationandfunction pages 1-2, typas2010regulationofpeptidoglycan pages 1-3, pazos2021regulationandfunction pages 2-4)
- Catalytic activities and substrates: PBP1A catalyzes (i) GTase activity (EC 2.4.99.28) that polymerizes glycan strands from the lipid II precursor and (ii) Ser-type D,D-TPase activity (EC 3.4.16.4) that crosslinks peptide stems to the existing sacculus. The TP reaction depends on ongoing GTase on the same enzyme; lipid II is the GT substrate. https://doi.org/10.1016/j.mib.2021.01.008; recent functional genetics confirm aPBP synthase–hydrolase coordination and stress-dependent performance differences between PBP1A and PBP1B in E. coli. https://doi.org/10.1128/mbio.00325-24 (pazos2021regulationandfunction pages 1-2, alodaini2024reducedpeptidoglycansynthesis pages 1-2, pazos2021regulationandfunction pages 6-7)
- Inhibitors: The TPase active site is acylated by β-lactam antibiotics, while the GTase is inhibited by moenomycin, which binds the donor glycan site. https://doi.org/10.1016/j.mib.2021.01.008; see Pseudomonas context for PBPs as β-lactam targets. https://doi.org/10.1128/aac.01651-16 (pazos2021regulationandfunction pages 1-2, chen2017penicillinbindingprotein3 pages 1-3, pazos2021regulationandfunction pages 2-4)
- Localization: PBP1A is inner-membrane anchored, with periplasmic catalytic domains acting at the peptidoglycan layer. aPBPs operate in complexes bridging the inner and outer membranes via periplasm-spanning partners. https://doi.org/10.1016/j.cell.2010.11.038; https://doi.org/10.1016/j.mib.2021.01.008 (typas2010regulationofpeptidoglycan pages 1-3, pazos2021regulationandfunction pages 1-2)
- Regulation by outer-membrane lipoproteins: In Gram-negative γ-proteobacteria, aPBPs require OM lipoprotein activators. E. coli PBP1A is activated by LpoA and PBP1B by LpoB. Pseudomonas species employ a related OM activator (LpoP) to stimulate cognate aPBP GT and TP activities (as summarized in Pazos & Vollmer 2021; foundational evidence from Typas et al. 2010 for OM regulation paradigm). https://doi.org/10.1016/j.mib.2021.01.008; https://doi.org/10.1016/j.cell.2010.11.038 (pazos2021regulationandfunction pages 6-7, typas2010regulationofpeptidoglycan pages 1-3, pazos2021regulationandfunction pages 2-4)

2) Recent developments and latest research (2023–2024)
- Stress-dependent division of labor between PBP1A and PBP1B: In E. coli, large-scale genetic interaction mapping and phenotyping under envelope stress show robust redundancy of aPBPs with notable stress dependencies—ΔmrcB (PBP1B) cells are specifically impaired at high salt, consistent with reduced PBP1A activity in vitro under high ionic strength. This clarifies environmental modulation of aPBP function and synthase–hydrolase robustness. mBio (Apr 2024). https://doi.org/10.1128/mbio.00325-24 (alodaini2024reducedpeptidoglycansynthesis pages 1-2)
- Continued consolidation of aPBP regulation mechanisms: Reviews emphasize that OM lipoprotein activators (LpoA/LpoB/LpoP) allosterically stimulate aPBP activities and integrate aPBPs with division and elongation systems, aligning with the periplasm-spanning regulation first defined by Typas et al. 2010. Current Opinion in Microbiology (Apr 2021). https://doi.org/10.1016/j.mib.2021.01.008 (pazos2021regulationandfunction pages 2-4, pazos2021regulationandfunction pages 6-7)

3) Current applications and real-world implementations
- Antibacterial targeting of aPBPs: β-lactams target the TPase domain of aPBPs, a cornerstone of clinical antibiotics. In Pseudomonas, PBPs are established β-lactam targets; essentiality varies by PBP and condition, affecting susceptibility and resistance profiling. Antimicrobial Agents and Chemotherapy (Jan 2017). https://doi.org/10.1128/aac.01651-16 (chen2017penicillinbindingprotein3 pages 1-3, chen2017penicillinbindingprotein3 pages 3-5)
- Chemical probes and natural products: Moenomycin is a well-characterized GTase inhibitor used extensively as a biochemical probe of aPBP polymerase function and to dissect synthase–hydrolase coordination. Mechanistic context summarized in Pazos & Vollmer 2021; Typas et al. 2010. https://doi.org/10.1016/j.mib.2021.01.008; https://doi.org/10.1016/j.cell.2010.11.038 (pazos2021regulationandfunction pages 1-2, typas2010regulationofpeptidoglycan pages 1-3)

4) Expert opinions and analysis from authoritative sources
- aPBPs as central, regulated synthases: Pazos & Vollmer synthesize structural, biochemical, and systems-level data to conclude that aPBPs are pivotal for peptidoglycan growth and repair, with activities critically controlled by OM lipoprotein activators and multi-enzyme complex formation. They note species differences in essentiality and functional partitioning, and that aPBPs provide mechanical stability (e.g., PBP1B loss decreases stiffness in E. coli). Current Opinion in Microbiology (Apr 2021). https://doi.org/10.1016/j.mib.2021.01.008 (pazos2021regulationandfunction pages 2-4, pazos2021regulationandfunction pages 6-7)
- OM-based regulation paradigm: Typas et al. defined the LpoA/LpoB activation of PBP1A/PBP1B, respectively, establishing the periplasm-spanning regulation concept that extends to Pseudomonas (with LpoP as a Pseudomonas-specific activator). Cell (Dec 2010). https://doi.org/10.1016/j.cell.2010.11.038 (typas2010regulationofpeptidoglycan pages 1-3)
- Pseudomonas PBPs and druggability: Chen et al. showed variable essentiality among high-molecular-mass PBPs in P. aeruginosa, with PBP3 essential and PBP1A disruptions affecting motility and morphology, supporting nuanced targeting strategies. Antimicrobial Agents and Chemotherapy (Jan 2017). https://doi.org/10.1128/aac.01651-16 (chen2017penicillinbindingprotein3 pages 3-5, chen2017penicillinbindingprotein3 pages 1-3)

5) Relevant statistics and data from recent studies
- E. coli genetic interaction mapping under stress (2024): Systematic interaction analysis of aPBPs with multiple hydrolases revealed few strict dependencies, underscoring robustness of PG growth; ΔmrcB showed significant fitness loss at high salt, with in vitro data indicating reduced PBP1A activity at high salt. mBio (Apr 2024). https://doi.org/10.1128/mbio.00325-24 (alodaini2024reducedpeptidoglycansynthesis pages 1-2)
- Mechanistic inhibition details: Moenomycin binds donor site in GT domain to block polymerization; β-lactams acylate TP active site serine. Structural and biochemical synthesis in reviews consolidate these mechanisms. Current Opinion in Microbiology (Apr 2021). https://doi.org/10.1016/j.mib.2021.01.008 (pazos2021regulationandfunction pages 2-4, pazos2021regulationandfunction pages 1-2)

Organism- and gene-specific synthesis for Pseudomonas putida KT2440 mrcA (Q88CU6)
- Mandatory verification: The gene symbol mrcA is widely used for PBP1A in Gram-negative bacteria. For P. putida KT2440, the ordered locus PP_5084 corresponds to PBP1A (per the prompt’s UniProt record Q88CU6). This matches the aPBP architecture and enzymology summarized in authoritative reviews and Pseudomonas literature, with no conflicting alternate gene identity found; thus, the symbol here is not ambiguous in this organismal context (supported by the conserved class A PBP features and OM-lipoprotein activation paradigm). https://doi.org/10.1016/j.mib.2021.01.008; https://doi.org/10.1016/j.cell.2010.11.038 (pazos2021regulationandfunction pages 1-2, typas2010regulationofpeptidoglycan pages 1-3)
- Primary function: A bifunctional peptidoglycan synthase performing GT (EC 2.4.99.28) using lipid II to polymerize glycan chains and TP (EC 3.4.16.4) to crosslink peptide stems; β-lactams inhibit TP and moenomycin inhibits GT. https://doi.org/10.1016/j.mib.2021.01.008 (pazos2021regulationandfunction pages 1-2, pazos2021regulationandfunction pages 2-4)
- Localization: Inner-membrane anchored with periplasmic catalytic domains that operate at the peptidoglycan layer. https://doi.org/10.1016/j.cell.2010.11.038 (typas2010regulationofpeptidoglycan pages 1-3)
- Regulation and partners: Expected activation by an OM lipoprotein (Lpo family); in Pseudomonas, the related activator LpoP stimulates its cognate aPBP’s GT and TP activities (summarized in Pazos & Vollmer). The aPBP also interacts functionally with peptidoglycan hydrolases, with coordinated activities essential for safe insertion and remodeling. https://doi.org/10.1016/j.mib.2021.01.008 (pazos2021regulationandfunction pages 6-7, pazos2021regulationandfunction pages 2-4)
- Roles in elongation and division: Class A PBPs contribute to both lateral wall growth and septal PG synthesis/repair, forming multi-enzyme complexes that integrate with divisome and elongasome components. https://doi.org/10.1016/j.mib.2021.01.008 (pazos2021regulationandfunction pages 1-2, pazos2021regulationandfunction pages 6-7)
- Essentiality and redundancy: Direct KT2440 knockout/essentiality data for mrcA are limited in the present evidence. In E. coli, PBP1A (mrcA) and PBP1B (mrcB) exhibit partial redundancy with stress-specific vulnerabilities (e.g., high-salt sensitivity without PBP1B due to reduced PBP1A activity). In Pseudomonas aeruginosa, most high-molecular-mass PBPs are individually nonessential under standard conditions, with PBP3 essential; PBP1A mutants show motility/morphology defects, illustrating organism-specific and condition-dependent requirements. Extrapolating cautiously, P. putida KT2440 mrcA likely functions redundantly with mrcB for core PG synthesis but may contribute distinctly to envelope robustness and fitness under specific stresses or growth regimes. https://doi.org/10.1128/mbio.00325-24; https://doi.org/10.1128/aac.01651-16 (alodaini2024reducedpeptidoglycansynthesis pages 1-2, chen2017penicillinbindingprotein3 pages 3-5, chen2017penicillinbindingprotein3 pages 1-3)

Pathway placement and mechanistic context
- Biosynthetic pathway: PBP1A acts late in the peptidoglycan pathway, using lipid II delivered to the periplasm to extend glycan chains and crosslink to the existing sacculus. aPBP function complements the SEDS–class B PBP (RodA–PBP2; FtsW–PBP3) machineries that form the core elongation and division synthases; aPBPs provide substantial flux and repair capacity and are integrated via periplasmic regulators. https://doi.org/10.1016/j.mib.2021.01.008 (pazos2021regulationandfunction pages 1-2, pazos2021regulationandfunction pages 6-7)
- Hydrolase coordination: Growth requires tightly coupled synthase–hydrolase action; large-scale interaction mapping shows no single amidase/endopeptidase is strictly required for either aPBP, highlighting robustness and distributed coordination. https://doi.org/10.1128/mbio.00325-24 (alodaini2024reducedpeptidoglycansynthesis pages 1-2)

Evidence limitations and notes
- While Pseudomonas aeruginosa PBPs have been systematically interrogated, direct genetic and biochemical characterizations specific to P. putida KT2440 mrcA (PP_5084) are limited in the present evidence set. Nevertheless, class A PBP architecture, regulation by OM lipoproteins (Lpo family), and enzymology are highly conserved in Gram-negative bacteria, supporting functional inference for KT2440. Future work should explicitly profile PP_5084 essentiality/phenotypes, map its lipoprotein activator (e.g., LpoP/LpoA ortholog reliance), and quantify stress-specific roles in KT2440. (pazos2021regulationandfunction pages 1-2, typas2010regulationofpeptidoglycan pages 1-3)

Key sources with URLs and dates
- Pazos M, Vollmer W. Regulation and function of class A penicillin-binding proteins. Current Opinion in Microbiology. Apr 2021. https://doi.org/10.1016/j.mib.2021.01.008 (pazos2021regulationandfunction pages 2-4, pazos2021regulationandfunction pages 6-7, pazos2021regulationandfunction pages 1-2)
- Typas A, et al. Regulation of peptidoglycan synthesis by outer membrane proteins. Cell. Dec 2010. https://doi.org/10.1016/j.cell.2010.11.038 (typas2010regulationofpeptidoglycan pages 1-3)
- Alodaini D, et al. Reduced peptidoglycan synthesis capacity impairs growth of E. coli at high salt concentration. mBio. Apr 2024. https://doi.org/10.1128/mbio.00325-24 (alodaini2024reducedpeptidoglycansynthesis pages 1-2)
- Chen W, Zhang Y-M, Davies C. Penicillin-Binding Protein 3 Is Essential for Growth of Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. Jan 2017. https://doi.org/10.1128/aac.01651-16 (chen2017penicillinbindingprotein3 pages 3-5, chen2017penicillinbindingprotein3 pages 1-3)

Conclusion
The Pseudomonas putida KT2440 mrcA gene product is a canonical class A PBP (PBP1A), a bifunctional peptidoglycan synthase that polymerizes lipid II-derived glycans and crosslinks peptide stems in the periplasm. Its TP activity is inhibited by β-lactams and its GT activity by moenomycin. aPBP activity and pathway integration are regulated by outer-membrane lipoprotein activators (Lpo family; Pseudomonas employs a related activator), and the enzyme functions within multi-protein complexes that coordinate with hydrolases during elongation and division. Recent work (2024) refines understanding of aPBP functional redundancy and environmental sensitivity, reinforcing the central yet regulated role of aPBPs in maintaining envelope integrity and antibiotic susceptibility in Gram-negative bacteria. (pazos2021regulationandfunction pages 1-2, typas2010regulationofpeptidoglycan pages 1-3, alodaini2024reducedpeptidoglycansynthesis pages 1-2, chen2017penicillinbindingprotein3 pages 3-5)

References

1. (pazos2021regulationandfunction pages 1-2): Manuel Pazos and Waldemar Vollmer. Regulation and function of class a penicillin-binding proteins. Current Opinion in Microbiology, 60:80-87, Apr 2021. URL: https://doi.org/10.1016/j.mib.2021.01.008, doi:10.1016/j.mib.2021.01.008. This article has 61 citations and is from a peer-reviewed journal.

2. (typas2010regulationofpeptidoglycan pages 1-3): Athanasios Typas, Manuel Banzhaf, Bart van den Berg van Saparoea, Jolanda Verheul, Jacob Biboy, Robert J. Nichols, Matylda Zietek, Katrin Beilharz, Kai Kannenberg, Moritz von Rechenberg, Eefjan Breukink, Tanneke den Blaauwen, Carol A. Gross, and Waldemar Vollmer. Regulation of peptidoglycan synthesis by outer membrane proteins. Cell, 143:1097-1109, Dec 2010. URL: https://doi.org/10.1016/j.cell.2010.11.038, doi:10.1016/j.cell.2010.11.038. This article has 460 citations and is from a highest quality peer-reviewed journal.

3. (alodaini2024reducedpeptidoglycansynthesis pages 1-2): Dema Alodaini, Victor Hernandez-Rocamora, Gabriela Boelter, Xuyu Ma, Micheal B. Alao, Hannah M. Doherty, Jack A. Bryant, Patrick Moynihan, Danesh Moradigaravand, Monika Glinkowska, Waldemar Vollmer, and Manuel Banzhaf. Reduced peptidoglycan synthesis capacity impairs growth of e. coli at high salt concentration. mBio, Apr 2024. URL: https://doi.org/10.1128/mbio.00325-24, doi:10.1128/mbio.00325-24. This article has 8 citations and is from a domain leading peer-reviewed journal.

4. (chen2017penicillinbindingprotein3 pages 1-3): Wei Chen, Yong-Mei Zhang, and Christopher Davies. Penicillin-binding protein 3 is essential for growth of pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy, Jan 2017. URL: https://doi.org/10.1128/aac.01651-16, doi:10.1128/aac.01651-16. This article has 91 citations and is from a highest quality peer-reviewed journal.

5. (pazos2021regulationandfunction pages 6-7): Manuel Pazos and Waldemar Vollmer. Regulation and function of class a penicillin-binding proteins. Current Opinion in Microbiology, 60:80-87, Apr 2021. URL: https://doi.org/10.1016/j.mib.2021.01.008, doi:10.1016/j.mib.2021.01.008. This article has 61 citations and is from a peer-reviewed journal.

6. (chen2017penicillinbindingprotein3 pages 3-5): Wei Chen, Yong-Mei Zhang, and Christopher Davies. Penicillin-binding protein 3 is essential for growth of pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy, Jan 2017. URL: https://doi.org/10.1128/aac.01651-16, doi:10.1128/aac.01651-16. This article has 91 citations and is from a highest quality peer-reviewed journal.

7. (pazos2021regulationandfunction pages 2-4): Manuel Pazos and Waldemar Vollmer. Regulation and function of class a penicillin-binding proteins. Current Opinion in Microbiology, 60:80-87, Apr 2021. URL: https://doi.org/10.1016/j.mib.2021.01.008, doi:10.1016/j.mib.2021.01.008. This article has 61 citations and is from a peer-reviewed journal.

Citations

1. alodaini2024reducedpeptidoglycansynthesis pages 1-2
2. typas2010regulationofpeptidoglycan pages 1-3
3. pazos2021regulationandfunction pages 1-2
4. pazos2021regulationandfunction pages 6-7
5. pazos2021regulationandfunction pages 2-4
6. https://www.uniprot.org/uniprot/Q88CU6
7. https://doi.org/10.1016/j.mib.2021.01.008
8. https://doi.org/10.1128/mbio.00325-24
9. https://doi.org/10.1128/aac.01651-16
10. https://doi.org/10.1016/j.cell.2010.11.038
11. https://doi.org/10.1016/j.mib.2021.01.008;
12. https://doi.org/10.1016/j.cell.2010.11.038;
13. https://doi.org/10.1128/mbio.00325-24;
14. https://doi.org/10.1016/j.mib.2021.01.008,
15. https://doi.org/10.1016/j.cell.2010.11.038,
16. https://doi.org/10.1128/mbio.00325-24,
17. https://doi.org/10.1128/aac.01651-16,

BioReason-Pro RL Review: mrcA (P. putida)

Source: mrcA-deep-research-bioreason-rl.md

• Correctness: 4/5
• Completeness: 3/5

Functional Summary Review

The BioReason functional summary describes mrcA as:

A soluble, bifunctional enzyme in Pseudomonas putida that assembles the bacterial cell wall. Its N-terminal module polymerizes glycan strands from lipid-linked precursors, while its C-terminal module cross-links peptide stems and is intrinsically susceptible to beta-lactam antibiotics. Acting on the cytoplasmic side of the envelope, it couples glycan elongation with peptide cross-linking to drive peptidoglycan biosynthesis and cell wall maturation.

The bifunctional enzyme description is correct -- mrcA/PBP1A has both glycosyltransferase (GT) and transpeptidase (TP) activities. The two-domain architecture is correctly identified:
- N-terminal GT51 domain for glycan strand polymerization
- C-terminal transpeptidase domain for peptide cross-linking
- Beta-lactam susceptibility

However, there are errors:

1. Wrong localization: The summary says mrcA acts "on the cytoplasmic side of the envelope" and is described as "soluble." In reality, PBP1A is an inner membrane-anchored protein with its catalytic domains operating in the periplasmic space. The curated review specifies plasma membrane and outer membrane-bounded periplasmic space as locations.

2. Missing regulation: The curated review notes that PBP1A activity is regulated by outer membrane lipoprotein activators (LpoA/LpoP family). This regulatory mechanism is not mentioned.

3. Missing redundancy context: PBP1A functions redundantly with PBP1B (mrcB) for core peptidoglycan synthesis but shows stress-specific requirements. This is not captured.

4. Missing antibiotic specificity: The GT domain is inhibited by moenomycin, and the TP domain is the target of beta-lactam antibiotics. Only beta-lactams are mentioned.

The thinking trace correctly identifies all seven InterPro domains including the GT51 family, transpeptidase domain, and the OB-like bridging domain. The mechanistic model of glycan elongation coupled with peptide cross-linking is accurate.

Comparison with interpro2go:

mrcA has no GO_REF:0000002 annotations in the curated review. BioReason's GO predictions include peptidoglycan biosynthetic process (GO:0009252) and cell wall biogenesis (GO:0042546), which align well with the curated core functions. The model correctly predicts the bifunctional nature from the domain architecture, which would not be obvious from a single interpro2go mapping. However, the localization predictions include outer membrane-bounded periplasmic space (GO:0030288) in the GO terms, which correctly contradicts the narrative's "cytoplasmic side" claim.

Notes on thinking trace

The trace provides good structural reasoning about the bifunctional architecture. However, the localization inference is flawed -- it states "the absence of transmembrane segments" when mrcA actually has an N-terminal transmembrane anchor. The mention of "RodA/PBP1 family systems" and "SEDS adaptor MreC" as interaction partners is relevant, showing some awareness of the elongasome context.